Total Wealth Planning & Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.52M Buy
53,407
+4,117
+8% +$110K 1.13% 13
2026
Q2
$1.19M Sell
49,290
-3,290
-6% -$86.1K 0.8% 28
2026
Q1
$1.48M Buy
52,580
+1,650
+3% +$43.9K 1.09% 15
2025
Q4
$1.27M Buy
+50,930
New +$1.28M 0.94% 20
2025
Q2
$922K Buy
38,048
+10,189
+37% +$238K 0.75% 32
2025
Q1
$706K Buy
27,859
+2,716
+11% +$71.1K 0.67% 40
2024
Q4
$667K Buy
+25,143
New +$682K 0.61% 42

Other funds holding PFE

Total Wealth Planning & Management's PFE Position: Q3 2026 in Review

Total Wealth Planning & Management increased its Pfizer (PFE) stake by 8.4% in Q3 2026, buying an estimated $110K and bringing the position to 53,407 shares worth $1.52M. The position accounts for 1.13% of the portfolio, ranked #13.

Total Wealth Planning & Management first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. 881 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Total Wealth Planning & Management held 53,407 shares of Pfizer worth $1.52M as of Q3 2026.
  • Total Wealth Planning & Management bought 4,117 Pfizer shares in Q3 2026, an estimated $110K.
  • Pfizer made up 1.13% of Total Wealth Planning & Management's portfolio in Q3 2026, its #13 holding.
  • Total Wealth Planning & Management first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • 881 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Total Wealth Planning & Management's 13F filing for Q3 2026, filed 23 Oct 2026.